![]() |
市场调查报告书
商品编码
1831939
2025-2033 年笔式针头市场报告(按类型、针头长度、疗法、购买方式、最终用户和地区)Pen Needles Market Report by Type, Needle Length, Therapy, Mode of Purchase, End User, and Region 2025-2033 |
2024年,全球注射笔针头市场规模达42亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到118亿美元,2025-2033年期间的复合年增长率(CAGR)为12.2%。糖尿病和慢性病盛行率上升、老年人口成长、医疗保健领域投资增加、技术快速进步、胰岛素自行注射的普及以及优惠报销政策的实施,这些因素共同推动着市场的发展。
糖尿病和其他慢性疾病的盛行率不断上升
全球糖尿病和其他慢性病的盛行率不断上升是推动注射笔针头市场成长的主要因素。根据国际糖尿病联盟 (IDF) 的《糖尿病地图集》,2021 年,20 至 79 岁成年人口中 10.5% 患有糖尿病,超过一半的人不知道自己被诊断出患有糖尿病。预测显示,到 2045 年,每八个成年人中就有一人(即近 7.83 亿人)将罹患糖尿病,增幅约 46%。因此,糖尿病管理需要频繁监测和注射胰岛素,而这可以透过配备注射笔针头的胰岛素笔来实现。对于需要频繁注射胰岛素的糖尿病患者来说,注射笔针头因其简单易用而成为不可或缺的工具。
老年人口不断扩大
笔式註射针市场预测强调,老年人口的成长是推动该市场成长的重要因素。由于与年龄相关的生理变化和更高的合併症盛行率,老年人更容易患上糖尿病等慢性疾病。根据世界卫生组织 (WHO) 预测,到 2050 年,全球 60 岁以上人口的比例预计将从 2015 年的 12% 增加近一倍至 22%。这种人口结构变化对医疗保健系统和医疗器材需求有着深远的影响。此外,设计有易于操作、疼痛最小化和安全性机制等特点的笔式註射针对这个年龄层的人也大有裨益。随着老年人口的持续增长,对满足其特定需求的产品的需求预计将增加,从而推动市场扩张。
医疗保健领域投资不断成长
多个国家加大对医疗保健产业的投入,增强了注射笔针头的市场份额。例如,2022 年,欧洲政府在卫生方面的整体支出为 1,2,210 亿欧元,占 GDP 的 7.7%。同样,印度的公共医疗保健支出在 2023 财年占 GDP 的 2.1%,在 2022 财年占 GDP 的 2.2%。这种扩张使得糖尿病等疾病的诊断、监测和管理得到改善,从而推动了对注射笔针头的需求。此外,具有成本效益的保险覆盖和报销计划的可用性一直在鼓励患者探索使用胰岛素笔和注射笔针头作为治疗选择。例如,2022 年期间,92.1% 的人(即美国的 3.04 亿人)在某个时候拥有健康保险,这也增加了对注射笔针头的需求。
标准笔针占据大部分市场份额
根据注射笔针头市场前景与分析,标准注射笔针头占据最大份额,这得益于其在患者和医护人员中的广泛使用和认可。这些针头设计适用于大多数胰岛素笔,并以其多功能性、易用性以及多种长度和规格的供应而闻名。此外,标准注射笔针头因其成本效益高以及与各种胰岛素输送系统相容的广泛选择而受到青睐。此外,设计和技术的不断改进提高了注射时的舒适度并减轻了疼痛,这也对注射笔针头的市场价值产生了积极影响。
8mm占据行业最大份额
根据注射笔针头市场报告及趋势,8毫米针头长度占据最大市场份额,这归功于其均衡的疗效和舒适度,适用于各类患者。此长度被认为是皮下胰岛素输送的最佳选择,既能确保胰岛素充分渗透皮下组织,又能最大限度地降低肌肉注射的风险。此外,8毫米针头因其多功能性而受到医疗保健提供者的广泛推荐,适合成人和儿童使用。此外,8毫米针头在临床实践中的广泛使用,加上患者的熟悉度和接受度,正在扩大注射笔针头的市场规模。
胰岛素占据主要市场份额
根据注射笔针头市场概况和细分,胰岛素治疗占据最大份额,这得益于糖尿病患病率的不断上升以及有效管理疾病的胰岛素注射的必要性。因此,胰岛素治疗需要频繁且精准的注射,这使得注射笔针头成为糖尿病患者的必备工具。此外,注射笔针头的便利性、准确性和疼痛减轻等特性的提升,提高了患者的依从性和生活质量,也促进了市场的成长。此外,先进胰岛素笔的研发和产品技术的持续创新也支撑了注射笔针头市场的价格趋势。
零售业在市场上占据明显主导地位
根据笔式针头市场研究报告,零售市场占据了最大份额,这得益于其为消费者提供的便利性和可及性。零售药局和线上商店为患者提供了便捷的即时获取管道,因为它们可以快速提供所需物资,无需前往医疗机构。此外,零售通路的广泛分销网络确保了广泛的供应,满足了城乡居民的需求。此外,零售店提供各种品牌和产品,使患者能够选择最符合其需求和偏好的笔式针头。
医院和诊所占据市场主导地位
医院和诊所构成了最大的细分市场,这得益于这些场所进行的大量医疗程序和慢性病管理。它们是主要的医疗保健提供者,大量糖尿病患者在这里接受诊断、制定治疗计划和持续管理,因此需要稳定的注射笔针头供应,用于胰岛素注射和其他注射疗法。此外,这些医疗机构优先考虑患者的安全和疗效,选择高品质的针头,以确保精准舒适的药物输送。此外,医院和诊所是患者正确使用这些针头的首要教育场所,这推动了市场的成长。
欧洲引领市场,占据注射笔针头最大市场份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,欧洲是笔式针头最大的区域市场。
欧洲占据着注射笔针头产业最大的市场份额,这得益于高糖尿病盛行率、先进的医疗基础设施以及政府的支持政策。同时,强大的医疗保健体系提供了广泛的糖尿病管理工具,加上强有力的报销框架的支持,减轻了患者的经济负担,这些因素正在推动市场成长。此外,人们对糖尿病照护的认知度高,积极进行公共卫生活动和推广注射笔针头的教育项目,也有利于市场成长。此外,多家领先的医疗器材製造商积极推动创新,并推动先进针头技术的普及,也刺激了注射笔针头市场的收入成长。
市场研究报告还对市场竞争格局进行了全面分析,并提供了所有主要公司的详细资料。笔式针头行业的一些主要市场参与者包括:
主要的注射笔针头公司正致力于创新、策略合作以及拓展全球业务,以维持并提升其市场地位。他们专注于透过超细和更短的针头进行创新,以提高患者的舒适度和依从性。此外,一些公司正利用其在胰岛素输送市场的强大影响力,将先进的注射笔针头与胰岛素笔集成,以确保无缝有效的糖尿病管理。此外,他们还致力于透过技术先进的解决方案扩展产品组合,并增强分销网络以覆盖更广泛的受众。此外,这些公司也积极参与策略合作和收购,以增强其市场地位和能力。
The global pen needles market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.2% during 2025-2033. The market is driven by the rising prevalence of diabetes and chronic diseases, expanding geriatric population, increasing investment in the healthcare sector, rapid technological advancements, growing self-administration of insulin, and the imposition of favorable reimbursement policies.
Increasing Prevalence of Diabetes and Other Chronic Diseases
The rising prevalence of diabetes and other chronic diseases across the globe is a major factor driving the pen needles market growth. According to the International Diabetes Federation's (IDF) Diabetes Atlas, 10.5% of the adult population aged 20 to 79 had diabetes in 2021, with over half unaware of the diagnosis. By 2045, this forecast predicts that one in every eight adults, or nearly 783 million, will have diabetes, which is an approximately 46% rise. In line with this, diabetes management necessitates frequent monitoring and insulin administration, which is accomplished with insulin pens equipped with pen needles. Pen needles are an indispensable tool for diabetes patients who require frequent insulin injections due to their ease and user-friendliness.
Expanding Geriatric Population
The pen needles market forecast highlights that the expanding geriatric population is a significant factor that is resulting in the growth of this market. Geriatric adults are more susceptible to chronic diseases, including diabetes, due to age-related physiological changes and a higher prevalence of comorbidities. According to the World Health Organization (WHO), the proportion of the world's population over 60 years is projected to nearly double from 12% in 2015 to 22% by 2050. This demographic shift has profound implications for healthcare systems and the demand for medical devices. Additionally, pen needles that are designed with features like easy handling, minimal pain, and safety mechanisms are beneficial for this age group. As the geriatric population continues to grow, the demand for products that are tailored to their specific needs is expected to increase, driving the expansion of the market.
Growing Investment in the Healthcare Sector
The increasing funding in the healthcare industry by several countries is strengthening the pen needle market share. For example, in 2022, Europe's overall government spending on health totaled €1221 Billion, or 7.7% of GDP. Similarly, India's public healthcare spending accounted for 2.1% of GDP in FY23 and 2.2% in FY22. This expansion has been allowing for improved diagnosis, monitoring, and management of illnesses such as diabetes, which drives up the demand for pen needles. Furthermore, the availability of cost-effective insurance coverage and reimbursement schemes have been encouraging patients to explore the use of insulin pens and pen needles as a treatment option. For instance, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during 2022, which also increased the pen needles demand.
Standard pen needles accounts for the majority of the market share
As per the pen needles market outlook and analysis, the standard pen needles segment represented the largest share, driven by their widespread usage and acceptance among patients and healthcare providers. These needles are designed to fit most insulin pens and are known for their versatility, ease of use, and availability in various lengths and gauges. Moreover, standard pen needles are preferred due to their cost-effectiveness and the broad range of options that ensure compatibility with various insulin delivery systems. Besides this, the continuous improvements in design and technology, which enhance comfort and reduce pain during injections, are positively impacting the pen needle market value.
8mm holds the largest share of the industry
Based on the pen needles market report and trends, the 8mm needle length segment holds the largest share in the market, attributed to its balanced efficacy and comfort for a wide range of patients. This length is considered optimal for subcutaneous insulin delivery, ensuring adequate penetration to the subcutaneous tissue while minimizing the risk of intramuscular injection. Moreover, the 8mm needles are widely recommended by healthcare providers due to their versatility, making them suitable for adults and children. Along with this, the extensive use of 8mm needles in clinical practice, coupled with patient familiarity and acceptance, is enhancing the pen needles market size.
Insulin represents the leading market segment
According to the pen needles market overview and segmentation, insulin therapy constituted the largest share, driven by the growing prevalence of diabetes and the necessity of insulin administration for effective disease management. In line with this, insulin therapy requires frequent and precise injections, making pen needles an essential tool for diabetic patients. Moreover, the rising convenience, accuracy, and reduced pain associated with pen needles that enhance patient compliance and quality of life are contributing to the market growth. Additionally, the development of advanced insulin pens and continuous innovations in product technology are supporting the pen needle market price trends.
Retail exhibits a clear dominance in the market
As per the pen needles market research report, the retail segment represented the largest share, driven by the convenience and accessibility it offers to consumers. Retail pharmacies and online stores provide an easy and immediate access point for patients as they offer quick supplies without the need for a medical facility visit. Besides this, the broad distribution networks of retail channels ensure widespread availability, catering to urban and rural populations. Additionally, retail outlets offer a variety of brands and products, allowing patients to choose pen needles that best meet their needs and preferences.
Hospitals and clinics dominate the market
Hospitals and clinics constituted the largest segment, driven by the high volume of medical procedures and chronic disease management performed in these settings. They are primary healthcare providers where a significant number of diabetes patients receive their diagnosis, treatment plans, and ongoing management, necessitating a steady supply of pen needles for insulin administration and other injectable therapies. Moreover, these healthcare facilities prioritize patient safety and efficacy, opting for high-quality needles to ensure precise and comfortable medication delivery. Additionally, hospitals and clinics serve as the first point of education for patients on the correct use of these needles, boosting the market growth.
Europe leads the market, accounting for the largest pen needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for pen needles.
Europe holds the largest segment in the pen needles industry, driven by a combination of high diabetes prevalence, advanced healthcare infrastructure, and supportive government policies. In line with this, the robust healthcare systems that provide extensive access to diabetes management tools, coupled with increased support from strong reimbursement frameworks that reduce the financial burden on patients, are boosting the market growth. Along with this, the high awareness of diabetes care, with proactive public health campaigns and educational programs that promote the use of these pens, is favoring the market growth. Additionally, the presence of several leading medical device manufacturers that foster innovation and boost the availability of advanced needle technologies is stimulating the pen needle market revenue.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the pen needles industry include:
The major pen needle companies are focusing on innovation, strategic partnerships, and expanding their global footprint to maintain and enhance their market positions. They are focusing on innovating with ultra-fine and shorter needles to improve patient comfort and compliance. Moreover, some players are leveraging their strong presence in the insulin delivery market to integrate advanced pen needles with their insulin pens to ensure seamless and effective diabetes management. Besides this, they are working on expanding their product portfolio with technologically advanced solutions and enhancing distribution networks to reach a broader audience. Moreover, these companies are actively involved in strategic collaborations and acquisitions to strengthen their market presence and capabilities.